A6791112
PF-04929113 (SNX-5422) , ≥98% , 908115-27-5
| Pack Size | Price | Stock | Quantity |
| 1MG | RMB367.20 | In Stock |
|
| 5MG | RMB1255.20 | In Stock |
|
| 10MG | RMB2183.20 | In Stock |
|
| 25mg | RMB3919.20 | In Stock |
|
| 50MG | RMB4951.20 | In Stock |
|
| 100mg | RMB7999.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 298-299℃ |
| Boiling point: | 646.5±55.0 °C(Predicted) |
| Density | 1.48 |
| storage temp. | Store at -20°C |
| solubility | ≥23.85 mg/mL in DMSO with gentle warming; insoluble in H2O; insoluble in EtOH |
| form | solid |
| pka | 15.07±0.50(Predicted) |
| color | White to off-white |
Description and Uses
PF 04929113 can be used in pharmacological activity and therapeutic use in therapeutic breast cancer drug target for multiclass comparative virtual screening to identify novel Hsp90 inhibitors. HSP90
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P280-P305+P351+P338 |
